Peritoneal Adhesiolysis with CC DRG Reimbursement Rates

DRG 336 applies to inpatient peritoneal adhesiolysis cases with Complication or Comorbidity, covering operative management of abdominal adhesions that impact patient recovery and resource needs. Correct coding and documentation of the procedure and associated comorbid conditions are important because they affect Diagnosis-Related Group assignment and Medicare payment for the hospitalization.

DRG 336 Overview

DRG 336 covers inpatient admissions for peritoneal adhesiolysis with Complication or Comorbidity where surgical intervention addresses abdominal adhesions causing obstruction or other complications. This Diagnosis-Related Group captures cases that typically involve operative management and may require increased resource use due to perioperative complexity. It matters for Medicare payment because the presence of a Complication or Comorbidity adjusts relative payment weights and influences hospital reimbursement for surgical and postoperative care. Accurate clinical coding and documentation of adhesiolysis procedures and associated comorbid conditions are essential to align billing with case complexity.

Acute surgical intervention trials evaluating optimized adhesiolysis techniques and intraoperative adjuncts: randomized or prospective cohort studies compare different surgical approaches (open laparotomy versus minimally invasive laparoscopy) and use of intraoperative measures (e.g., meticulous sharp dissection protocols, adhesion barrier application, or optimized hemostasis strategies) in patients undergoing peritoneal adhesiolysis with a complication or comorbidity burden that qualifies them for this DRG. These studies enroll patients presenting with adhesive small-bowel obstruction, chronic adhesive pain, or recurrent obstruction requiring operative adhesiolysis, and measure intraoperative blood loss, operating time, complication rates, need for bowel resection, and short-term ICU use. Results are highly relevant to surgeons and hospital payers because they can influence index hospitalization resource utilization, complication-driven cost variation, and selection of surgical approach tied to reimbursement under this DRG.
Comparative effectiveness and complication-reduction studies assessing perioperative care bundles: prospective comparative studies or pragmatic trials test enhanced recovery protocols, perioperative antibiotic stewardship, thromboembolism prevention strategies, and standardized criteria for bowel resection in patients undergoing peritoneal adhesiolysis with significant comorbidities (e.g., prior abdominal surgeries, advanced age, or malnutrition). The focus is on reducing postoperative complications such as surgical site infection, anastomotic leak when bowel resection is performed, prolonged ileus, and unplanned returns to the OR, with endpoints including length of stay, readmission rates, and need for postoperative intensive care. These trials are important to providers and payers because improved perioperative pathways can lower complication-related costs, shorten hospital stays under the DRG payment window, and reduce penalties associated with readmissions.
Post-discharge outcomes and health services research examining long-term functional recovery, readmission drivers, and cost trajectories: cohort studies and registry-based analyses follow patients discharged after adhesiolysis to evaluate long-term pain control, recurrent obstruction rates, dependence on home health or durable medical equipment, and patterns of emergency visits and readmissions over 30–90 days. These studies often stratify by factors such as extent of adhesiolysis, whether bowel resection was performed, presence of ostomy, and social determinants of health to identify predictors of resource use and patient-centered outcomes. Findings inform case management, discharge planning, and payer strategies by identifying which subgroups benefit from targeted post-discharge interventions to reduce costly readmissions and improve recovery after a hospitalization captured by this DRG.

Acute surgical intervention trials evaluating optimized adhesiolysis techniques and intraoperative adjuncts: randomized or prospective cohort studies compare different surgical approaches (open laparotomy versus minimally invasive laparoscopy) and use of intraoperative measures (e.g., meticulous sharp dissection protocols, adhesion barrier application, or optimized hemostasis strategies) in patients undergoing peritoneal adhesiolysis with a complication or comorbidity burden that qualifies them for this DRG. These studies enroll patients presenting with adhesive small-bowel obstruction, chronic adhesive pain, or recurrent obstruction requiring operative adhesiolysis, and measure intraoperative blood loss, operating time, complication rates, need for bowel resection, and short-term ICU use. Results are highly relevant to surgeons and hospital payers because they can influence index hospitalization resource utilization, complication-driven cost variation, and selection of surgical approach tied to reimbursement under this DRG.
Comparative effectiveness and complication-reduction studies assessing perioperative care bundles: prospective comparative studies or pragmatic trials test enhanced recovery protocols, perioperative antibiotic stewardship, thromboembolism prevention strategies, and standardized criteria for bowel resection in patients undergoing peritoneal adhesiolysis with significant comorbidities (e.g., prior abdominal surgeries, advanced age, or malnutrition). The focus is on reducing postoperative complications such as surgical site infection, anastomotic leak when bowel resection is performed, prolonged ileus, and unplanned returns to the OR, with endpoints including length of stay, readmission rates, and need for postoperative intensive care. These trials are important to providers and payers because improved perioperative pathways can lower complication-related costs, shorten hospital stays under the DRG payment window, and reduce penalties associated with readmissions.
Post-discharge outcomes and health services research examining long-term functional recovery, readmission drivers, and cost trajectories: cohort studies and registry-based analyses follow patients discharged after adhesiolysis to evaluate long-term pain control, recurrent obstruction rates, dependence on home health or durable medical equipment, and patterns of emergency visits and readmissions over 30–90 days. These studies often stratify by factors such as extent of adhesiolysis, whether bowel resection was performed, presence of ostomy, and social determinants of health to identify predictors of resource use and patient-centered outcomes. Findings inform case management, discharge planning, and payer strategies by identifying which subgroups benefit from targeted post-discharge interventions to reduce costly readmissions and improve recovery after a hospitalization captured by this DRG.

OpenPayer

Summary & Overview

Peritoneal Adhesiolysis with CC: Inpatient Reimbursement Overview

DRG 336 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes